Bank of New York Mellon’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-92,835
| Closed | -$1.46M | – | 4363 |
|
|
2023
Q4 | $1.46M | Buy |
92,835
+872
| +0.9% | +$13.7K | ﹤0.01% | 2981 |
|
|
2023
Q3 | $713K | Buy |
91,963
+7,210
| +9% | +$55.9K | ﹤0.01% | 3360 |
|
|
2023
Q2 | $842K | Buy |
84,753
+15,319
| +22% | +$152K | ﹤0.01% | 3298 |
|
|
2023
Q1 | $403K | Sell |
69,434
-954
| -1% | -$5.53K | ﹤0.01% | 3603 |
|
|
2022
Q4 | $559K | Buy |
70,388
+5,481
| +8% | +$43.5K | ﹤0.01% | 3486 |
|
|
2022
Q3 | $205K | Buy |
64,907
+6,972
| +12% | +$22K | ﹤0.01% | 4007 |
|
|
2022
Q2 | $332K | Sell |
57,935
-5,906
| -9% | -$33.8K | ﹤0.01% | 3826 |
|
|
2022
Q1 | $449K | Buy |
63,841
+25,741
| +68% | +$181K | ﹤0.01% | 3772 |
|
|
2021
Q4 | $872K | Buy |
38,100
+5,479
| +17% | +$125K | ﹤0.01% | 3463 |
|
|
2021
Q3 | $965K | Buy |
+32,621
| New | +$965K | ﹤0.01% | 3412 |
|